A team of researchers at the University of Glasgow in Scotland has developed a 3d drug printing and analysis system that is cheaper and faster than traditional processes, according to a study published Thursday in the journal Science.
“I believe that the system will change the way we manufacture fine chemicals and possibly medicines. We will increase confidence (in the system), so we expect the industry to get it right,” explained one of the members of the team, Professor Lee Cronin.
In addition, Cronin stressed that the system is capable of causing chemicals to stabilize and isolate themselves, as in the traditional chemical industry.
According to the authors of the study, drug manufacturing factories are expensive and difficult to reuse for different drugs.
The system created by Professor Philip Kitson and his colleagues, in turn, uses custom models for the synthesis of substances using simple plastic modules, which can be packaged and used elsewhere, at low cost.
Software that identifies the chemical reactions and processes required for each drug generates components that can be printed on a cheap $ 2,000 3D printer.
The researchers proved the system’s ability to produce baclofen, a muscle relaxant, and found that they could use it to prepare the drug in three steps: identifying chemical reactions and processes, translating 3D models, and printing the medicine.
For the authors, this system has multiple benefits, including universal access, a more efficient distribution and the possibility of being cheaper than the traditional industry.